Chen Guang-Liang, Xia Zu-Guang, Jin Jia, Yu Bao-Hua, Cao Junning
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Department of Oncology, Shanghai Medical College of Fudan University, Shanghai 200032, China.
J Oncol. 2021 Jan 25;2021:3869438. doi: 10.1155/2021/3869438. eCollection 2021.
Pyothorax-associated lymphoma (PAL) is a rare disease developing from a long-term pleural cavity inflammation. Most reported PAL cases have a history of artificial pneumothorax. However, the clinical features of artificial pneumothorax-unrelated PAL remain largely unknown. Here, we reported two PAL cases diagnosed from our center in the past ten years. One case developed from asymptomatic pyothorax after pneumonectomy with a latency of 28 years, while the other case showed a relatively short latency of one year. Then we reviewed the literature of artificial pneumothorax-unrelated PAL by searching PubMed and Google Scholar from 2007. In total, nine artificial pneumothorax-unrelated PAL cases were found, predominantly in old male with median age of 76 years (ranging from 51 to 88). Most cases were diagnosed with diffuse large B-cell lymphoma (DLBCL) ( = 8, 88.9%) and had evidence of Epstein-Barr virus (EBV) infection ( = 6, 66.7%) or tuberculous pleurisy ( = 5, 55.6%). Notably, four cases (44.4%) had short intervals (no more than two years) between pleuritis and PAL. Regarding the overall survival, one-third cases survived more than 5 years after the diagnosis of PAL. In conclusion, the features of artificial pneumothorax-unrelated PAL are comparable with the classic type of PAL, except for some patients with short duration of pleuritis, and need to be identified. Treatment guideline of DLBCL is recommended for the management of PAL.
脓胸相关淋巴瘤(PAL)是一种由长期胸腔炎症发展而来的罕见疾病。大多数报道的PAL病例有人工气胸病史。然而,与人工气胸无关的PAL的临床特征仍 largely未知。在此,我们报告了过去十年在我们中心诊断的两例PAL病例。一例在肺切除术后由无症状脓胸发展而来,潜伏期为28年,而另一例潜伏期相对较短,为一年。然后,我们通过检索2007年以来的PubMed和谷歌学术,回顾了与人工气胸无关的PAL的文献。总共发现了9例与人工气胸无关的PAL病例,主要为老年男性,中位年龄为76岁(范围为51至88岁)。大多数病例被诊断为弥漫性大B细胞淋巴瘤(DLBCL)(=8,88.9%),并有EB病毒(EBV)感染证据(=6,66.7%)或结核性胸膜炎证据(=5,55.6%)。值得注意的是,4例(44.4%)在胸膜炎和PAL之间的间隔时间较短(不超过两年)。关于总生存期,三分之一的病例在PAL诊断后存活超过5年。总之,除了一些胸膜炎病程较短的患者外,与人工气胸无关的PAL的特征与经典类型的PAL相当,需要加以识别。建议采用DLBCL的治疗指南来管理PAL。